Intervention Review

Sertindole for schizophrenia

  1. Ruth Lewis1,*,
  2. Anne-Marie Bagnall2,
  3. Maria Leitner3

Editorial Group: Cochrane Schizophrenia Group

Published Online: 20 JUL 2005

Assessed as up-to-date: 24 MAY 2005

DOI: 10.1002/14651858.CD001715.pub2


How to Cite

Lewis R, Bagnall AM, Leitner M. Sertindole for schizophrenia. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD001715. DOI: 10.1002/14651858.CD001715.pub2.

Author Information

  1. 1

    Cardiff University, Department of Primary Care and Public Health, Wrexham, UK

  2. 2

    Leeds Metropolitan University, Faculty of Health, Leeds, UK

  3. 3

    University of Liverpool, Faculty of Medicine, Liverpool, UK

*Ruth Lewis, Department of Primary Care and Public Health, Cardiff University, Centre for Health Sciences / North Wales Clinical School, School of Medicine, Gwenfro Building, Wrexham, LL13 7YP, UK. lewisr17@Cardiff.ac.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 20 JUL 2005

SEARCH

  1. Current Version

    Sertindole for schizophrenia

    Ruth Lewis, Anne-Marie Bagnall and Maria Leitner

    Article first published online: 20 JUL 2005 | DOI: 10.1002/14651858.CD001715.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Sertindole for schizophrenia

    R Lewis, A-M Bagnall and M Leitner

    Article first published online: 24 APR 2000 | DOI: 10.1002/14651858.CD001715